Related Experiment Video
Updated: Jul 14, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Rifampicin induced thrombocytopenia
1Department of Pulmonary Medicine, King George's Medical University, Lucknow. rgarg70@rediffmail.com
Abstract:
Thrombocytopenia is an uncommon but potentially life threatening complication of certain anti-tubercular drugs and is characterized by rapid destruction of platelets whenever an offending drug is taken by a susceptible person. Here is a case report of Rifampicin induced Thrombocytopenia. This case is being reported for purpose of its rare occurrence and documentation.
Related Concept Videos
Rocky Mountain Spotted Fever
Inhibitors of Viral Protein Synthesis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacokinetics: Drug–Drug Interactions
Cryptococcal Meningitis
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions